MANBA expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.925200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.997700E-02
Normal-vs-Stage2
3.456600E-01
Normal-vs-Stage3
1.672800E-01
Normal-vs-Stage4
7.792400E-01
Stage1-vs-Stage2
6.231900E-02
Stage1-vs-Stage3
6.700600E-01
Stage1-vs-Stage4
9.904100E-02
Stage2-vs-Stage3
2.829600E-01
Stage2-vs-Stage4
5.299600E-01
Stage3-vs-Stage4
2.551800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.869200E-01
Normal-vs-AfricanAmerican
3.581200E-01
Normal-vs-Asian
1.233780E-01
Caucasian-vs-AfricanAmerican
8.416000E-01
Caucasian-vs-Asian
4.447800E-01
AfricanAmerican-vs-Asian
4.197400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.131000E-01
Normal-vs-Female
2.846400E-01
Male-vs-Female
8.620000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.930600E-01
Normal-vs-Age(41-60Yrs)
5.459200E-01
Normal-vs-Age(61-80Yrs)
1.961440E-01
Normal-vs-Age(81-100Yrs)
3.833800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.705800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.932800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.365000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.643500E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.390200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.384600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.008400E-01
Normal-vs-Daily Drinker
2.529000E-01
Normal-vs-Weekly Drinker
1.951650E-01
Normal-vs-Occasional Drinker
4.582000E-01
Normal-vs-Social Drinker
1.957830E-01
Non Drinker-vs-Daily Drinker
9.540400E-01
Non Drinker-vs-Weekly Drinker
9.151800E-01
Non Drinker-vs-Occasional Drinker
6.675600E-01
Non Drinker-vs-Social Drinker
8.687800E-01
Daily Drinker-vs-Weekly Drinker
9.523600E-01
Daily Drinker-vs-Occasional Drinker
7.012200E-01
Daily Drinker-vs-Social Drinker
9.030600E-01
Weekly Drinker-vs-Occasional Drinker
7.594000E-01
Weekly Drinker-vs-Social Drinker
9.493200E-01
Occasional Drinker-vs-Social Drinker
7.897600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.132800E-01
Normal-vs-Grade 2
1.323210E-01
Normal-vs-Grade 3
1.667630E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.605290E-04
Grade 1-vs-Grade 3
2.625000E-04
Grade 1-vs-Grade 4
7.132800E-01
Grade 2-vs-Grade 3
2.233800E-01
Grade 2-vs-Grade 4
1.323210E-01
Grade 3-vs-Grade 4
1.667630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.886200E-01
Normal-vs-NonDiabetic
2.669600E-01
Diabetic-vs-NonDiabetic
9.990600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.574600E-01
Normal-vs-NoPancreatitis
2.455600E-01
Pancreatitis-vs-NoPancreatitis
1.022440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.843250E-01
Normal-vs-N1
3.870200E-01
N0-vs-N1
3.941800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.943200E-01
Normal-vs-TP53-NonMutant
5.683900E-02
TP53-Mutant-vs-TP53-NonMutant
1.884920E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
